Showing results (61-70 of 106) with videos related to

Sort By:
Pageof 11
Cancer Chemotherapy and Pharmacology|June 1, 2010
Marginal increase of sunitinib exposure by grapefruit juiceNielka P van Erp, Sharyn D Baker, Anthe S Zandvliet, et al.
Clinical Pharmacokinetics|July 29, 2020
Model-Informed Precision Dosing of Everolimus: External Validation in Adult Renal Transplant RecipientsTom C Zwart, Dirk Jan A R Moes, Paul J M van der Boog, et al.
British Journal of Clinical Pharmacology|August 6, 2024
Exploring the contribution of genetic variants to high sunitinib exposure in patients with cancerEline L Giraud, Stefanie D Krens, Stefan Böhringer, et al.
British Journal of Clinical Pharmacology|May 14, 2017
Optimizing the dose in cancer patients treated with imatinib, sunitinib and pazopanibNienke A G Lankheet, Ingrid M E Desar, Sasja F Mulder, et al.
Future Oncology (London, England)|December 4, 2013
Mammalian target of rapamycin inhibitor-associated stomatitisChristine B Boers-Doets, Judith E Raber-Durlacher, Nathaniel S Treister, et al.
European Journal of Cancer (Oxford, England : 1990)|January 26, 2016
Positron emission tomography response criteria in solid tumours criteria for quantitative analysis of [18F]-fluorodeoxyglucose positron emission tomography with integrated computed tomography for treatment response assessment in metastasised solid tumours: All that glitters is not goldAnnelieke E C A B Willemsen, Myrella Vlenterie, Carla M L van Herpen, et al.
Pharmaceutical Research|October 17, 2019
Does Older Age Lead to Higher Risk for Neutropenia in Patients Treated with Paclitaxel?Marie-Rose B S Crombag, Stijn L W Koolen, Sophie Wijngaard, et al.
Targeted Oncology|April 13, 2018
The Impact of Dose and Simultaneous Use of Acid-Reducing Agents on the Effectiveness of Vemurafenib in Metastatic BRAF V600 Mutated Melanoma: a Retrospective Cohort StudyLotte M Knapen, Rutger H T Koornstra, Johanna H M Driessen, et al.
Anticancer Research|March 8, 2019
Early Metabolic Response as a Predictor of Treatment Outcome in Patients With Metastatic Soft Tissue SarcomasMyrella Vlenterie, Wim Jg Oyen, Neeltje Steeghs, et al.
British Journal of Clinical Pharmacology|September 27, 2018
Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis: a clinical pharmacological perspective on a surgical procedureLoek A W de Jong, Fortuné M K Elekonawo, Philip R de Reuver, et al.
Pageof 11